InsidersTradesSigma
Follow the Baijin Life Science Holdings Ltd. share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Retail sector, Baijin Life Science Holdings Ltd. has logged 9 reports. Market capitalisation: €932.3m. The latest transaction was reported on 29 April 2026 (Purchase). Among the most active insiders: CHENG Chi Kin. The full history is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
9 ops.
Buy Volume
n/a
n/a
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,469 of 29,062 companies
16.5
score / 100
Value25
Quality8
FCF yld-2.9%
Earn yld-4.8%
EV/EBITDA·
ROE-25%
Gross mgn7.5%
Net mgn-42%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 April 2026
Declarations9 total
1,000,000 sharesShareXHKGHKEX:DA20260428E00528
932,000 sharesShareXHKGHKEX:DA20260428E00519
2,000,000 sharesShareXHKGHKEX:DA20260428E00340
2,933,765 sharesShareXHKGHKEX:DA20260429E00164
9,322,540 sharesShareXHKGHKEX:DA20260428E00086
932,000 sharesShareXHKGHKEX:DA20260428E00295
9 of 9 declarations
Acerca de Baijin Life Science Holdings Ltd.
Baijin Life Science Holdings Ltd. es una empresa centrada en la distribución de productos relacionados con las ciencias de la vida. Cotiza en la Bolsa de Hong Kong.